Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday''s Pre-Market Session
Gainers Dave Inc. (NASDAQ: DAVE ) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022. Pzena Investment Management, Inc (NYSE: PZN ) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise quarterly sales. Teva Pharmaceutical Industries Limited (NYSE: TEVA ) rose 18.3% to $8.42 in pre-market trading after the company reported better-than-expected financial results. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN ) rose 18.1% to $0.31 in pre-market trading after declining more than 9% on Tuesday. AIM ImmunoTech Inc. (NYSE: AIM ) rose 16.4% to $0.8380 in pre-market trading. AIM ImmunoTech recently reported follow-on data from its published single-center named patient program. GeoVax Labs, Inc. (NASDAQ: GOVX ) rose 15.7% to $1.97 in pre-market trading. GeoVax Labs is expected to report second quarter 2022 financial results on Wednesday, August 3, 2022.
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday''s Pre-Market Session
Gainers Dave Inc. (NASDAQ: DAVE ) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022. Pzena Investment Management, Inc (NYSE: PZN ) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise quarterly sales. Teva Pharmaceutical Industries Limited (NYSE: TEVA ) rose 18.3% to $8.42 in pre-market trading after the company reported better-than-expected financial results. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN ) rose 18.1% to $0.31 in pre-market trading after declining more than 9% on Tuesday. AIM ImmunoTech Inc. (NYSE: AIM ) rose 16.4% to $0.8380 in pre-market trading. AIM ImmunoTech recently reported follow-on data from its published single-center named patient program. GeoVax Labs, Inc. (NASDAQ: GOVX ) rose 15.7% to $1.97 in pre-market trading. GeoVax Labs is expected to report second quarter 2022 financial results on Wednesday, August 3, 2022.